Year |
Citation |
Score |
2020 |
Booker BE, Steg AD, Kovac S, Landen CN, Amm HM. The use of hedgehog antagonists in cancer therapy: a comparison of clinical outcomes and gene expression analyses. Cancer Biology & Therapy. 1-11. PMID 32914706 DOI: 10.1080/15384047.2020.1806640 |
0.41 |
|
2020 |
Warram JM, Napier TS, Udayakumar N, Jani AH, Hartman YE, Houson HA, Moore L, Amm HM, van den Berg NS, Sorace AG. Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme. Molecular Cancer Therapeutics. PMID 32606015 DOI: 10.1158/1535-7163.Mct-19-0819 |
0.345 |
|
2020 |
Morlandt AB, Moore LS, Johnson AO, Smith CM, Stevens TM, Warram JM, MacDougall M, Rosenthal EL, Amm HM. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. PMID 32554066 DOI: 10.1016/J.Joms.2020.05.022 |
0.368 |
|
2020 |
Kovac S, Napier TS, Scoffield J, Amm HM. Abstract 2634: Oral bacteria effects on oral cancer initiation and progression Cancer Research. 80: 2634-2634. DOI: 10.1158/1538-7445.Am2020-2634 |
0.409 |
|
2019 |
Kovac S, Napier T, Scoffield J, Amm H. Abstract 132: Direct interactions of oral bacteria and oral squamous cell carcinoma cells Cancer Research. 79: 132-132. DOI: 10.1158/1538-7445.Sabcs18-132 |
0.444 |
|
2016 |
Amm HM, MacDougall M. Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis. Current Oral Health Reports. 3: 82-92. PMID 27547697 DOI: 10.1007/S40496-016-0085-Z |
0.407 |
|
2014 |
Steg AD, Burke MR, Amm HM, Katre AA, Dobbin ZC, Jeong DH, Landen CN. Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer. Oncotarget. 5: 7065-80. PMID 25216523 DOI: 10.18632/Oncotarget.2295 |
0.465 |
|
2014 |
Amm HM, Casimir MD, Clark DB, Sohn P, MacDougall M. Matrix metalloproteinase expression in keratocystic odontogenic tumors and primary cells. Connective Tissue Research. 55: 97-101. PMID 25158190 DOI: 10.3109/03008207.2014.923875 |
0.361 |
|
2014 |
Lu C, Mamaeva OA, Cui C, Amm H, Rutsch F, MacDougall M. Establishment of Singleton-Merten syndrome pulp cells: evidence of mineralization dysregulation. Connective Tissue Research. 55: 57-61. PMID 25158182 DOI: 10.3109/03008207.2014.923880 |
0.355 |
|
2014 |
Amm HM, Rollins DL, Ren C, Dong J, DeVilliers P, Rivera H, MacDougall M. Establishment and characterization of a primary calcifying epithelial odontogenic tumor cell population. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 43: 183-90. PMID 24118390 DOI: 10.1111/Jop.12125 |
0.38 |
|
2013 |
Kerr EH, Frederick PJ, Egger ME, Stockard CR, Sellers J, DellaManna D, Oelschlager DK, Amm HM, Eltoum IE, Straughn JM, Buchsbaum DJ, Grizzle WE, McNally LR. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Annals of Surgical Oncology. 20: 3059-65. PMID 23525731 DOI: 10.1245/S10434-013-2878-9 |
0.563 |
|
2012 |
Ren C, Amm HM, DeVilliers P, Wu Y, Deatherage JR, Liu Z, MacDougall M. Targeting the sonic hedgehog pathway in keratocystic odontogenic tumor. The Journal of Biological Chemistry. 287: 27117-25. PMID 22679015 DOI: 10.1074/Jbc.M112.367680 |
0.448 |
|
2011 |
Amm HM, Buchsbaum DJ. Relationship between galectin-3 expression and TRAIL sensitivity in breast cancer. Expert Review of Anticancer Therapy. 11: 1193-6. PMID 21916572 DOI: 10.1586/Era.11.108 |
0.591 |
|
2011 |
Ren C, Diniz MG, Piazza C, Amm HM, Rollins DL, Rivera H, Devilliers P, Kestler DP, Waite PD, Mamaeva OA, Macdougall M. Differential enamel and osteogenic gene expression profiles in odontogenic tumors. Cells, Tissues, Organs. 194: 296-301. PMID 21597274 DOI: 10.1159/000324759 |
0.424 |
|
2011 |
Amm HM, Zhou T, Steg AD, Kuo H, Li Y, Buchsbaum DJ. Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. Molecular Cancer Research : McR. 9: 403-17. PMID 21357440 DOI: 10.1158/1541-7786.Mcr-10-0133 |
0.611 |
|
2011 |
Amm HM, Oliver PG, Lee CH, Li Y, Buchsbaum DJ. Combined modality therapy with TRAIL or agonistic death receptor antibodies. Cancer Biology & Therapy. 11: 431-49. PMID 21263219 DOI: 10.4161/Cbt.11.5.14671 |
0.599 |
|
2011 |
Bevis KS, McNally LR, Sellers JC, Della Manna D, Londoño Joshi A, Amm H, Straughn JM, Buchsbaum DJ. Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecologic Oncology. 121: 193-9. PMID 21211830 DOI: 10.1016/J.Ygyno.2010.11.046 |
0.578 |
|
2011 |
Kerr EH, Frederick PJ, Oelschlager DK, Amm H, Sellers J, Manna DD, Buchsbaum DJ, Grizzle WE, McNally LR. Abstract 1714: Chemoresistance in patients with papillary serous carcinoma of the ovary Cancer Research. 71: 1714-1714. DOI: 10.1158/1538-7445.Am2011-1714 |
0.596 |
|
2010 |
Steg A, Amm HM, Novak Z, Frost AR, Johnson MR. Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Cancer Biology & Therapy. 10: 893-902. PMID 20814245 DOI: 10.4161/Cbt.10.9.13252 |
0.481 |
|
Show low-probability matches. |